Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges [Yahoo! Finance]
Nyxoah SA - Ordinary Shares (NYXH)
Company Research
Source: Yahoo! Finance
For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Nyxoah SA ( NASDAQ:NYXH ) received U.S. FDA approval for Genio in August 2025 and successfully launched the product in the U.S. market. The company secured reimbursement for Genio across both Medicare and commercial payers, resulting in initial implants and revenue generation as early as September 2025. Nyxoah SA ( NASDAQ:NYXH ) trained 145 surgeons in 125 high-volume hypoglossal nerve stimulation accounts, achieving $4.5 million in revenue in Q4 2025. The DREAM pivotal study was published, demonstrating Genio's clinical efficacy in both supine and non-supine positions, differentiating it from competitors. The company reported a global gross revenue of EUR 11 million for 2025, driven by strong U.S. launch momentum. Negative Points Total operating loss for the full year 2025 was EUR 83.5 million, an increase from EUR 58.8 million in 2024, reflecting the c
Show less
Read more
Impact Snapshot
Event Time:
NYXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYXH alerts
High impacting Nyxoah SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NYXH
News
- Publication relating to transparency notificationsGlobeNewswire
- Nyxoah (NYXH) had its price target lowered by Stifel Nicolaus from $11.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Nyxoah Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsGlobeNewswire
- Publication relating to transparency notificationGlobeNewswire
NYXH
Earnings
- 3/19/26 - Beat
NYXH
Sec Filings
- 3/19/26 - Form 6-K
- 1/30/26 - Form 6-K
- 1/14/26 - Form 6-K
- NYXH's page on the SEC website